At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 82 enrolled
Drug / intervention
TAK-114 10 mg capsule +1 moredrug
Likely dose
TAK-114 10 mg capsulefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single-center, Single- and Multiple-Dose Phase 1 Study to Evaluate the Safety and Pharmacokinetics of TAK-114 in Healthy Adult Japanese and Caucasian Male Subjects
In Brief
A Phase 1 clinical trial evaluating TAK-114 10 mg capsule and TAK-114 matched placebo for Clinical Pharmacology. Completed, enrolled 82 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety and tolerability of TAK-114 following single and multiple ascending oral doses in healthy Japanese male participants.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsClinical Pharmacology
CountriesJapan
Collaborators--
Timeline
Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartNov 2014
First PostedNov 2014
Primary CompletionApr 2015
TodayJul 2026
First PostedNov 7, 2014
Enrollment StartNov 1, 2014
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 11.7 years ago
Interventions
TAK-114 10 mg capsuledrug
TAK-114 matched placebodrug